Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.

Su, Shao-Hua

Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling. [electronic resource] - Behavioural brain research 10 2016 - 334-344 p. digital

Publication Type: Journal Article

1872-7549

10.1016/j.bbr.2016.07.009 doi


Animals
Benzamides--pharmacology
Benzoxazines--pharmacology
Cannabinoid Receptor Agonists--pharmacology
Carbamates--pharmacology
Cognitive Dysfunction--drug therapy
Fatty Acids--metabolism
Glycogen Synthase Kinase 3--metabolism
Long-Term Potentiation--drug effects
Male
Maze Learning--physiology
Mixed Function Oxygenases--antagonists & inhibitors
Morpholines--pharmacology
Naphthalenes--pharmacology
Neuroprotective Agents--pharmacology
Phosphatidylinositol 3-Kinases--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Rats, Sprague-Dawley
Receptors, Cannabinoid--drug effects
Signal Transduction--drug effects